Literature DB >> 7810126

Prenatal substance use in a Western urban community.

K F Buchi1, M W Varner.   

Abstract

To assess the extent of prenatal substance use in a predominantly white population in an urban area of the western United States and to develop a risk profile for this population, a cross-sectional prevalence study was done. Prenatal clinics (10 public and 10 private) anonymously recorded demographic information about and collected aliquots of routinely obtained urine specimens from women during prenatal visits. Urine specimens were screened by enzyme immunoassay for amphetamines, marijuana, cocaine, opiates, and ethanol. Of the 935 women screened, 92 (9.8%) had urine specimens positive for one or more of these substances. Urine screens were positive in 56 (10.0%) of 562 women attending private clinics and 36 (9.6%) of 373 women attending public clinics. Only 7 of the 935 women (0.7%) had screens positive for cocaine. Ethanol was the most frequently detected substance in the private clinic group (6.4%), whereas marijuana was most common among women attending public clinics (5.1%). Although substance use in this group of pregnant women occurs at a lower rate and a different pattern from those found in other more densely populated areas, the rate is high enough to be of concern to all prenatal care professionals, who should incorporate substance use history taking and selective urine drug screening into their routine prenatal practices.

Entities:  

Mesh:

Year:  1994        PMID: 7810126      PMCID: PMC1022676     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  10 in total

1.  Routine urine drug screening at the first prenatal visit.

Authors:  G H Colmorgen; C Johnson; M A Zazzarino; K Durinzi
Journal:  Am J Obstet Gynecol       Date:  1992-02       Impact factor: 8.661

2.  The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida.

Authors:  I J Chasnoff; H J Landress; M E Barrett
Journal:  N Engl J Med       Date:  1990-04-26       Impact factor: 91.245

3.  Prevalence of use of cocaine and other substances in an obstetric population.

Authors:  C Matera; W B Warren; M Moomjy; D J Fink; H E Fox
Journal:  Am J Obstet Gynecol       Date:  1990-09       Impact factor: 8.661

Review 4.  Analytical methodology.

Authors:  R L Hawks
Journal:  NIDA Res Monogr       Date:  1986

5.  Anonymous cocaine screening in a private obstetric population.

Authors:  M S Burke; D Roth
Journal:  Obstet Gynecol       Date:  1993-03       Impact factor: 7.661

6.  Specificity of the EMIT drug abuse urine assay methods.

Authors:  L V Allen; M L Stiles
Journal:  Clin Toxicol       Date:  1981-09       Impact factor: 4.467

7.  The perinatal impact of cocaine, amphetamine, and opiate use detected by universal intrapartum screening.

Authors:  K M Gillogley; A T Evans; R L Hansen; S J Samuels; K K Batra
Journal:  Am J Obstet Gynecol       Date:  1990-11       Impact factor: 8.661

8.  Drug abuse screening of childbearing-age women in Alabama public health clinics.

Authors:  S K George; J Price; J C Hauth; D M Barnette; P Preston
Journal:  Am J Obstet Gynecol       Date:  1991-10       Impact factor: 8.661

9.  Substance abuse during pregnancy in a rural population.

Authors:  L B Sloan; J W Gay; S W Snyder; W R Bales
Journal:  Obstet Gynecol       Date:  1992-02       Impact factor: 7.661

10.  The prevalence of substance abuse among pregnant women in Utah.

Authors:  K F Buchi; M W Varner; R A Chase
Journal:  Obstet Gynecol       Date:  1993-02       Impact factor: 7.661

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.